Ophthalmology, Retina Specialist · Pinellas Park, FL
NPI
1083603146
Since 2005
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
9375 66th St N
Pinellas Park, FL, 33782
Phone (727) 365-7376
Groups this clinician bills Medicare through
Medicare paid, 2024
$793K
10,249 services
Medicare patients, 2024
302
Average age 79
Drug cost, 2024
$2.0M
966 prescriptions
Company payments, 2025
$530
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason M Handza was code J2777 (injection, faricimab-svoa, 0.1 mg), 6,181 times for 21 patients. In total Jason M Handza billed 10,249 services in 28 codes, and Medicare paid $793K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 6,181 | 21 | $27.33 | $169K |
| 92134 Computerized Ophthalmic Imaging | Office | 732 | 273 | $30.03 | $22K |
| 92014 Ophthalmological E&M | Office | 549 | 296 | $87.22 | $48K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 522 | 19 | $262.64 | $137K |
| 67028 Intravitreal Injection | Office | 517 | 108 | $92.26 | $48K |
| J0178 Injection, aflibercept, 1 mg | Office | 268 | 35 | $640.62 | $172K |
| J7999 Compounded drug, not otherwise classified | Office | 111 | 35 | $61.36 | $6,810 |
| J3490 Unclassified drugs | Office | 101 | 18 | $619.66 | $63K |
| 92012 Ophthalmological E&M | Office | 73 | 55 | $66.85 | $4,880 |
| 92250 Angiography | Office | 58 | 52 | $28.26 | $1,639 |
By year: 2022 $519K for 3,375 services; 2023 $581K for 9,355 services; 2024 $793K for 10,249 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jason M Handza prescribed most often to Medicare patients was Eylea (Aflibercept), with 337 prescriptions and refills. In total Jason M Handza wrote 966 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 337 | 350 | 104 | $737K |
| Eylea Hd Aflibercept | 239 | 247 | 53 | $698K |
| Vabysmo Faricimab-Svoa | 78 | 81 | 23 | $181K |
| Ketorolac Tromethamine Generic | 49 | 84 | 21 | $1,862 |
| Izervay Avacincaptad Pegol Sodium/Pf | 41 | 41 | Under 11 | $117K |
| Syfovre Pegcetacoplan/Pf | 33 | 33 | Under 11 | $117K |
| Lucentis Ranibizumab | 26 | 28 | Under 11 | $63K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 18 | 31 | Under 11 | $221 |
| Latanoprost Generic | 17 | 32 | Under 11 | $161 |
| Ozurdex Dexamethasone | 15 | 37 | Under 11 | $22K |
| Prednisolone Acetate Generic | 15 | 28 | Under 11 | $823 |
| Brimonidine Tartrate Generic | 11 | 32 | Under 11 | $295 |
Brand drugs: 839 claims; generic drugs: 127 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason M Handza $530 ($530 in general payments such as food, travel and fees) from 12 companies. The largest payer was Amgen Inc. with $195.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.